BioLife Solutions, Inc.
General ticker "BLFS" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.2B (TTM average)
BioLife Solutions, Inc. follows the US Stock Market performance with the rate: 35.0%.
Estimated limits based on current volatility of 1.9%: low 20.82$, high 21.60$
Factors to consider:
- Total employees count: 159 (-61.6%) as of 2024
- Top business risk factors: Pandemic risks, Product performance, Labor/talent shortage/retention, Manufacturing risks, Litigation risks
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [19.86$, 31.29$]
- 2026-12-31 to 2027-12-31 estimated range: [19.90$, 31.43$]
Financial Metrics affecting the BLFS estimates:
- Negative: with PPE of -118.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: 0.07 < Operating cash flow per share per price, % of 1.68
- Positive: -8.75 < Industry operating profit margin (median), % of -1.25
- Positive: -3.36 < Return on assets ratio (scaled to [-100,100]) of -2.90
- Positive: -14.24 < Investing cash flow per share per price, % of -5.98
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 2.91
Short-term BLFS quotes
Long-term BLFS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $75.86MM | $82.25MM | $96.21MM |
| Operating Expenses | $99.30MM | $89.38MM | $108.34MM |
| Operating Income | $-23.44MM | $-7.13MM | $-12.13MM |
| Non-Operating Income | $4.97MM | $-4.30MM | $0.05MM |
| Interest Expense | $1.45MM | $0.72MM | $2.71MM |
| R&D Expense | $12.07MM | $7.91MM | $7.57MM |
| Income(Loss) | $-18.47MM | $-11.43MM | $-12.08MM |
| Taxes | $-0.02MM | $-0.04MM | $0.05MM |
| Other Income(Loss) | $-49.55MM | $-8.80MM | $0.00MM |
| Profit(Loss)* | $-66.43MM | $-28.98MM | $-24.26MM |
| Stockholders Equity | $337.66MM | $348.91MM | $371.89MM |
| Inventory | $43.46MM | $29.01MM | $30.16MM |
| Assets | $412.71MM | $399.49MM | $405.88MM |
| Operating Cash Flow | $-12.50MM | $8.43MM | $20.11MM |
| Capital expenditure | $6.38MM | $3.23MM | $9.48MM |
| Investing Cash Flow | $17.84MM | $58.30MM | $-71.54MM |
| Financing Cash Flow | $10.59MM | $-6.78MM | $-10.92MM |
| Earnings Per Share** | $-1.52 | $-0.63 | $-0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.